Hostname: page-component-745bb68f8f-5r2nc Total loading time: 0 Render date: 2025-01-11T15:55:36.677Z Has data issue: false hasContentIssue false
  • English
  • Français

What Will it Take to Address the Global Threat of Antibiotic Resistance?

Published online by Cambridge University Press:  01 January 2021

Steven J. Hoffman  and
Kevin Outterson
Get access Rights & Permissions [Opens in a new window]

Extract

Of the many global health challenges facing the world today, only a small number require global collective action. Most health challenges can be fully addressed through action at local, regional or national levels.

What kind of actions must be taken to address the global threat of antibiotic resistance (ABR)? What legal, political and economic tools might be needed to achieve this level of action?

In March 2015 the Dag Hammarskjöld Foundation convened a workshop in Uppsala, Sweden to address these questions in partnership with the Global Strategy Lab, the Journal of Law, Medicine & Ethics (JLME), the Norwegian Institute of Public Health, and ReAct — Action on Antibiotic Resistance. Eleven concise articles were commissioned to explore whether ABR depended on global collective action, and if so, what tools could help states and non-state actors to achieve it.

Type
Independent
Information
Journal of Law, Medicine & Ethics , Volume 43 , Issue 2 , Summer 2015 , pp. 363 - 368
Copyright
Copyright © American Society of Law, Medicine and Ethics 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hammarskjöld Foundation, D., “Who We Are,” available at <http://www.daghammarskjold.se/who-we-are> (last visited June 10, 2015).+(last+visited+June+10,+2015).>Google Scholar
Global Strategy Lab, “Mission,” available at <http://www.globalstrategy.ninja/about> (last visited June 10, 2015).+(last+visited+June+10,+2015).>Google Scholar
American Society of Law, Medicine & Ethics, Journal of Law, Medicine & Ethics, “Back Issues and Articles,” available at <http://www.aslme.org/Back_Issues_And_Articles?journal=JLME> (last visited June 10, 2015).+(last+visited+June+10,+2015).>Google Scholar
Norwegian Institute of Public Health, “Better Health for All,” available at <http://www.fhi.no/eway/?pid=240> (last visited June 10, 2015).+(last+visited+June+10,+2015).>Google Scholar
ReAct – Action on Antibiotic Resistance, “Who We Are,” available at <http://www.reactgroup.org/who-we-are.html> (last visited June 10, 2015).+(last+visited+June+10,+2015).>Google Scholar
Barlam, T. F. Gupta, K., “Antibiotic Resistance Spreads Across Borders,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.CrossRefGoogle Scholar
Hoffman, S. J. Outterson, K. Røttingen, J.-A. Cars, O. Clift, C. Rizvi, Z. et al., “An International Legal Framework to Address Antimicrobial Resistance,” Bulletin of the World Health Organization 93, no. 2 (2015): 66.Google Scholar
Daulaire, N. Bang, A. Tomson, G. Kalyango, J. N. Cars, O., “Universal Access to Effective Antimicrobials: An Essential Feature of Global Collective Action against Antimicrobial Resistance,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.Google Scholar
Review on Antimicrobial Resistance, “Tackling Drug-Resistant Infections Globally,” available at <http://amr-review.org/home> (last visited June 11, 2015).+(last+visited+June+11,+2015).>Google Scholar
Clift, C. Gopinathan, U. Morel, C. Outterson, K. Røttingen, J.-A. So, A. D., Towards a New Global Business Model for Antibiotics: Report from the Chatham House Working Group on New Antibiotic Business Models (Chatham House, 2015).Google Scholar
World Health Organization: Draft Global Action Plan on Antimicrobial Resistance, World Health Organization, available at <http://www.who.int/drugresistance/AMR_DRAFT_GAP_1_Oct_2014_for_MS_consultation.pdf> (last visited June 11, 2015).+(last+visited+June+11,+2015).>Google Scholar
Outterson, K. Powers, J. H. Daniels, G. W. McClellan, M. B., “Repairing the Broken Market for Antibiotic Innovation,” Health Affairs 34, no. 2 (2015): 277–285.CrossRefGoogle Scholar
Balasegaram, M. Clift, C. Røttingen, J.-A., “A Pathway towards an Alternative Business Model for Antibiotic Innovation: A Framework, Fund and Institutional Mechanism,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.Google Scholar
Podolsky, S. H. Bud, R. Gradmann, C. Hobaek, B. Kirchhelle, C. Mitvedt, T. Santesmases, M. J. Thoms, U. Berild, D. Kveim Lie, A., “History Teaches Us That Confronting Antibiotic Resistance Requires Stronger Global Collective Action,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.CrossRefGoogle Scholar
Hollis, A. Maybarduk, P., “Antibiotic Resistance Is a Tragedy of the Commons That Necessitates Global Cooperation,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.Google Scholar
So, A. D. Shah, T. A. Roach, S. Chee, Y. L. Nachman, K. E., “International Agreement to Address the Contribution of Animal Agriculture to Antibiotic Resistance: A One Health Approach,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.Google Scholar
Andresen, S. Hoffman, S. J., “Much Can Be Learned about Addressing Antibiotic Resistance from Multilateral Environmental Agreements,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.Google Scholar
Ottersen, T. Hoffman, S. J., “Addressing Antibiotic Resistance Requires Robust International Accountability Mechanisms,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.Google Scholar
Hoffman, S. J. Røttingen, J.-A. Frenk, J., “International Law Has a Role to Play in Addressing Antibiotic Resistance,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.Google Scholar
Hoffman, S. J. Røttingen, J.-A., “A Framework Convention on Obesity Control?” The Lancet 378, no. 9809 (2011): 2068; Hoffman, S. J. Røttingen, J.-A., “Be Sparing With International Laws,” Nature 483, no. 7389 (2012): 275; Hoffman, S. J. Røttingen, J.-A., “Dark Sides of the Proposed Framework Convention on Global Health's Many Virtues: A Systematic Review and Critical Analysis,” Health and Human Rights 15, no. 1 (2013): E117–E134; Hoffman, S. J. Røttingen, J.-A., “Assessing the Expected Impact of Global Health Treaties: Evidence from 90 Quantitative Evaluations,” American Journal of Public Health 105, no. 1 (2015): 26–40; Hoffman, S. J. Røttingen, J.-A. Frenk, J., “Assessing Proposals for New Global Health Treaties: An Analytic Framework,” American Journal of Public Health (2015): e1–e8.Google Scholar
See Hoffman, Røttingen, Frenk, , supra note 20.Google Scholar
Behdinan, A. Hoffman, S. J. Pearcey, M., “Some Global Policies for Antibiotic Resistance Depend on Legally Binding and Enforceable Commitments,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.CrossRefGoogle Scholar
Rizvi, Z. Hoffman, S. J., “Effective Global Action on Antibiotic Resistance Requires Careful Consideration of Convening Forums,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.CrossRefGoogle Scholar
Hoffman, S. J., “A Science of Global Strategy,” in Frenk, J. Hoffman, S. J., eds., “To Save Humanity”: What Matters Most for a Healthy Future (New York: Oxford University Press, 2015): At 173–175.Google Scholar
ReAct – Action on Antibiotic Resistance, “Royal Recognition and New Antibiotics Center Confirmed,” available at <http://www.reactgroup.org/news/496/18.html> (last visited June 10, 2015).+(last+visited+June+10,+2015).>Google Scholar